Skip to content

OPTILATER - Optimal long-term survival after cancer

OPTILATER - Optimal long-term survival after cancer - OPTILATER

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00032146
Enrollment
3000
Registered
2024-03-12
Start date
2024-04-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C00-C97

Interventions

Group 1: WP1 - Healthcare analysis (Analysis from health insurance data) Group 2: WP2 - Focusgroups and individual Interviews (Individual and group interviews) Group 3: WP3 - Quantitative interviews

Sponsors

Universitätsklinikum Essen (Westdeutsches Tumorzentrum)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients who have been diagnosed with cancer at least five years ago are included in the trial.

Exclusion criteria

Exclusion criteria: Patients who have been diagnosed with cancer under five years ago will not be included in the trial.

Design outcomes

Primary

MeasureTime frame
Development of recommendations for action to address the needs of primary and secondary cancer survivors

Secondary

MeasureTime frame
Identification of gaps in knowledge about cancer survivorship care

Countries

Germany

Contacts

Public ContactLara Pfeiffer

Universitätsklinikum Essen

optilater@uk-essen.de+49201 7230

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026